Gruss Capital Management LP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gruss Capital Management LP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$582,000
+58.2%
600,000
+97.4%
0.02%
+50.0%
Q4 2015$368,000
-83.7%
304,0000.0%0.01%
-83.1%
Q3 2015$2,259,000
+3.9%
304,0000.0%0.07%
-7.8%
Q2 2015$2,174,000
-16.7%
304,0000.0%0.08%
-28.0%
Q1 2015$2,611,000
-5.1%
304,000
+10.1%
0.11%
+35.4%
Q4 2014$2,752,000
-44.4%
276,000
-44.8%
0.08%
-29.5%
Q3 2014$4,950,000500,0000.11%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders